Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting cyclooxygenase enzyme for the adjuvant COVID‐19 therapy
Parteek Prasher, Mousmee Sharma, Ravi Gunupuru
Drug Development Research (2021) Vol. 82, Iss. 4, pp. 469-473
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

COVID-19 and the role of cytokines in this disease
Amin Hasanvand
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 789-798
Open Access | Times Cited: 92
Beneficial Properties of Bromelain
Paweł Hikisz, Joanna Bernasińska
Nutrients (2021) Vol. 13, Iss. 12, pp. 4313-4313
Open Access | Times Cited: 71
Oxidative stress and inflammatory markers in patients with COVID-19: Potential role of RAGE, HMGB1, GFAP and COX-2 in disease severity
Fabíolla Rocha Santos Passos, Luana Heimfarth, Brenda Souza Monteiro, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108502-108502
Open Access | Times Cited: 52
Evaluating NSAIDs in SARS-CoV-2: Immunomodulatory mechanisms and future therapeutic strategies
Said Moshawih, Qais Jarrar, Abdul Alim Bahrin, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25734-e25734
Open Access | Times Cited: 5
Organotin(IV) complexes: Emerging Frontiers in anticancer therapeutics and bioimaging applications
Yang Zi, Fahad A. Alhumaydhi, Waleed Al Abdulmonem, et al.
Coordination Chemistry Reviews (2025) Vol. 534, pp. 216582-216582
Closed Access
Indomethacin for refractory COVID or post-COVID headache: a retrospective study
Abouch Valenty Krymchantowski, Raimundo Pereira Silva‐Néto, Carla Jevoux, et al.
Acta Neurologica Belgica (2021) Vol. 122, Iss. 2, pp. 465-469
Open Access | Times Cited: 39
Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus
Olivier Terrier, Sébastien Dilly, Andrés Pizzorno, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2593-2593
Open Access | Times Cited: 38
A Home-Treatment Algorithm Based on Anti-inflammatory Drugs to Prevent Hospitalization of Patients With Early COVID-19: A Matched-Cohort Study (COVER 2)
Elena Consolaro, Fredy Suter, Nadia Rubis, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 24
Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era
Basil Mohammed Alomair, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 11
Inhibitory effect of food-functioned phytochemicals on dysregulated inflammatory pathways triggered by SARS-CoV-2: a mechanistic review
Ibrahim Jantan, Nor Azrina Norahmad, Yuandani Yuandani, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-26
Closed Access | Times Cited: 3
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Management of Mild-to-Moderate Symptomatic COVID-19
Sergio Fazio, Flora Affuso, Paolo Bellavite
Medical Science Monitor (2022) Vol. 28
Open Access | Times Cited: 17
Acetylsalicylic Acid–Primus Inter Pares in Pharmacology
Łukasz Fijałkowski, Magdalena Skubiszewska, Grzegorz Grześk, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8412-8412
Open Access | Times Cited: 16
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between November 2020 and August 2021
Sergio Fazio, Paolo Bellavite, Elisabetta Zanolin, et al.
Medical Science Monitor (2021) Vol. 28
Open Access | Times Cited: 19
Oxidative stress and COVID-19-associated neuronal dysfunction: mechanisms and therapeutic implications
Dylan Bowen, Suhrud Pathak, Rishi Nadar, et al.
Acta Biochimica et Biophysica Sinica (2023) Vol. 55, Iss. 8, pp. 1153-1167
Open Access | Times Cited: 6
Design, synthesis, and biological evaluation of new 2-(4-(methylsulfonyl)phenyl)-N-phenylimidazo[1,2-a]pyridin-3-amine as selective COX-2 inhibitors
Mahsa Azami Movahed, Fatemeh Abbası, Mahsa Rajabi, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 5, pp. 856-868
Open Access | Times Cited: 5
Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease
Gusti Putu Wahyunanda Crista Yuda, Naufa Hanif, Adam Hermawan
DARU Journal of Pharmaceutical Sciences (2023) Vol. 32, Iss. 1, pp. 47-65
Closed Access | Times Cited: 5
Imrecoxib: Advances in Pharmacology and Therapeutics
Yanhong Wang, Lingling Zhu, Tianlang Li, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1711-1725
Open Access | Times Cited: 1
Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin
Sergio Fazio, Paolo Bellavite
BioMed (2023) Vol. 3, Iss. 1, pp. 177-194
Open Access | Times Cited: 4
Home pharmacological therapy in early COVID‐19 to prevent hospitalization and reduce mortality: Time for a suitable proposal
Sergio Pandolfi, Salvatore Chirumbolo, Giovanni Ricevuti, et al.
Basic & Clinical Pharmacology & Toxicology (2021) Vol. 130, Iss. 2, pp. 225-239
Open Access | Times Cited: 11
Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host
Shivangi Agrawal, Ekta Pathak, Rajeev Mishra, et al.
Computers in Biology and Medicine (2022) Vol. 149, pp. 106049-106049
Open Access | Times Cited: 7
Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling
Panagiotis Zagaliotis, Anthi Petrou, George A. Mystridis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 8006-8006
Open Access | Times Cited: 6
Mimicking Gene–Environment Interaction of Higher Altitude Dwellers by Intermittent Hypoxia Training: COVID-19 Preventive Strategies
Rashmi Supriya, Kumar Purnendu Singh, Yang Gao, et al.
Biology (2022) Vol. 12, Iss. 1, pp. 6-6
Open Access | Times Cited: 6
Targeting Mucin Hypersecretion in COVID-19 Therapy
Parteek Prasher, Mousmee Sharma
Future Medicinal Chemistry (2022) Vol. 14, Iss. 10, pp. 681-684
Open Access | Times Cited: 4
Bromelain Supplementation in the Management of Otitis Media with Effusion in Children
Francesco Martines, Ginevra Malta, Emanuele Cannizzaro, et al.
Children (2024) Vol. 11, Iss. 12, pp. 1440-1440
Open Access
Page 1 - Next Page

Scroll to top